Compounds > mibefradil
Page last updated: 2024-08-24

mibefradil and kys 05090

mibefradil has been researched along with kys 05090 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Choe, YJ; Choi, JY; Joo, DJ; Kim, J; Kim, Y; Lee, JY; Lee, SH; Rhim, H; Seo, HN1
Cho, S; Choi, DL; Choi, HE; Choi, HW; Huang, M; Jang, SJ; Kim, KS; Lee, JY; Lee, KT; Rhim, H; Rim, HK1
Chung, KS; Gandini, MA; Jang, C; Kim, M; Ko, D; Lee, JY; Lee, KT; Moon, YH; Nam, Y; Ryu, KD; Zamponi, GW1

Other Studies

3 other study(ies) available for mibefradil and kys 05090

ArticleYear
Discovery of potent T-type calcium channel blocker.
    Bioorganic & medicinal chemistry letters, 2007, Nov-01, Volume: 17, Issue:21

    Topics: Calcium Channel Blockers; Calcium Channels, T-Type; Cell Line; Humans; Quinazolines; Structure-Activity Relationship

2007
In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.
    Bioorganic & medicinal chemistry letters, 2013, Dec-15, Volume: 23, Issue:24

    Topics: Calcium Channel Blockers; Calcium Channels, T-Type; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; Humans; Ovarian Neoplasms; Quinazolines; Structure-Activity Relationship

2013
Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers.
    Bioorganic & medicinal chemistry, 2020, 06-01, Volume: 28, Issue:11

    Topics: Antineoplastic Agents; Calcium Channel Blockers; Calcium Channels, T-Type; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured

2020